Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.598, 2010-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
NICE recommends nilotinib and golimumab . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. :
Access to resources
Recommend
Dasatinib/imatinib/nilotinib: Cardiomyopathy (first report for nilotinib): case report
Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. :
Dasatinib/imatinib/nilotinib: Myelosuppression: case report
Reactions Weekly, Vol. 1, Iss. 1351, 2011-01 ,pp. :
Nilotinib, dasatinib or imatinib in CML: no clear winner
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. :
Nilotinib better than imatinib, dasatinib for CML in Colombia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. :